Strong track record of project delivery and line leadership. Experience of developing late phase assets (led the Chemical Development Project Teams for the oral products abacavir and naratriptan and heavily involved in registration and launch of the intranasal product Veramyst). Significant experience of working in the drug development matrix (member of several Product Development Teams). Experience working at the Discovery/Development and Development/Manufacturing interfaces. From 2001 worked closely with the Respiratory Centre of Excellence for Drug Discovery (CEDD) at GSK and was regarded as one of the more influential preclinical partners. Very adept at working with third parties (I provided expert support for all inhaled licensing opportunities at GSK). Played a key role in shaping how Chemical Development at GSK supported the development of inhaled products.